Javier Zelaya, M.D., P.C.
NPI 1760494355 · Specialist · Brooklyn, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Javier Zelaya, M.D., P.C. is a Specialist provider in Brooklyn, NY (NPI 1760494355).
Provider details
- NPI number
- 1760494355
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D., P.C.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 187832 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,611 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,645 | $95 |
| Test for Allergy Using Skin Patch95044 | 1,360 | $6 |
| Biopsy of Related Skin Growth, First Growth11102 | 594 | $49 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 379 | $7 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 289 | $120 |
| Destruction of Skin Growth, 1-14 Growths17110 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 38 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 414 | 282 |
| Ketoconazole | 377 | 174 |
| Mometasone Furoate | 304 | 171 |
| Betamethasone Dipropionate | 144 | 79 |
| Hydrocortisone | 123 | 93 |
| Clobetasol Propionate | 123 | 63 |
| Mupirocin | 120 | 73 |
| Ammonium Lactate | 102 | 52 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$231 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-12
- Last updated
- 2007-07-08
Frequently asked questions
- What is Javier Zelaya's NPI number?
- Javier Zelaya's National Provider Identifier (NPI) is 1760494355, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Javier Zelaya's specialty?
- Javier Zelaya is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Javier Zelaya located?
- Javier Zelaya's practice location on file with NPPES is 254 Prospect Park W, Brooklyn, NY 11215-5806.
- What is Javier Zelaya's phone number?
- The practice phone number listed in the NPPES registry for Javier Zelaya is (718) 832-3313.
- Does Javier Zelaya accept Medicare?
- Javier Zelaya is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Javier Zelaya's NPI active?
- Yes — Javier Zelaya's NPI (1760494355) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.